Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation - PubMed (original) (raw)
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation
M Stein et al. J Exp Med. 1992.
Abstract
Expression of the macrophage mannose receptor is inhibited by interferon gamma (IFN-gamma), a T helper type 1 (Th-1)-derived lymphokine. Interleukin 4 (IL-4), a Th-2 lymphocyte product, upregulates major histocompatibility class II antigen expression but inhibits inflammatory cytokine production by macrophages. We have studied the effect of IL-4 on expression of the macrophage mannose receptor (MMR) by elicited peritoneal macrophages. We found that recombinant murine IL-4 enhances MMR surface expression (10-fold) and activity (15-fold), as measured by the respective binding and degradation of 125I-mannose-bovine serum albumin. Polymerase chain reaction analysis of cDNAs from purified primary macrophage populations revealed that MMR, but not lysozyme or tumor necrosis factor alpha, mRNA levels were markedly increased by IL-4. The above effects were associated with morphologic changes. These data establish IL-4 as a potent and selective enhancer of murine MMR activity in vitro. IL-4 induces inflammatory macrophages to adopt an alternative activation phenotype, distinct from that induced by IFN-gamma, characterized by a high capacity for endocytic clearance of mannosylated ligands, enhanced (albeit restricted) MHC class II antigen expression, and reduced proinflammatory cytokine secretion.
Similar articles
- Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma.
Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S. Doyle AG, et al. Eur J Immunol. 1994 Jun;24(6):1441-5. doi: 10.1002/eji.1830240630. Eur J Immunol. 1994. PMID: 7911424 - Interaction and regulation of macrophage receptors.
Ezekowitz RA, Gordon S. Ezekowitz RA, et al. Ciba Found Symp. 1986;118:127-36. doi: 10.1002/9780470720998.ch9. Ciba Found Symp. 1986. PMID: 3089710 Review. - Recognition of complex carbohydrates by the macrophage mannose receptor.
Taylor ME. Taylor ME. Biochem Soc Trans. 1993 May;21(2):468-73. doi: 10.1042/bst0210468. Biochem Soc Trans. 1993. PMID: 8359512 Review. No abstract available.
Cited by
- The increase in mannose receptor recycling favors arginase induction and Trypanosoma cruzi survival in macrophages.
Garrido VV, Dulgerian LR, Stempin CC, Cerbán FM. Garrido VV, et al. Int J Biol Sci. 2011;7(9):1257-72. doi: 10.7150/ijbs.7.1257. Epub 2011 Oct 25. Int J Biol Sci. 2011. PMID: 22110379 Free PMC article. - Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17.
Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanović R. Staples KJ, et al. J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7. doi: 10.1016/j.jaci.2012.07.023. Epub 2012 Sep 14. J Allergy Clin Immunol. 2012. PMID: 22981793 Free PMC article. - Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.
Vicetti Miguel RD, Harvey SA, LaFramboise WA, Reighard SD, Matthews DB, Cherpes TL. Vicetti Miguel RD, et al. PLoS One. 2013;8(3):e58565. doi: 10.1371/journal.pone.0058565. Epub 2013 Mar 13. PLoS One. 2013. PMID: 23555586 Free PMC article. Clinical Trial. - Fatty acid oxidation of alternatively activated macrophages prevents foam cell formation, but Mycobacterium tuberculosis counteracts this process via HIF-1α activation.
Genoula M, Marín Franco JL, Maio M, Dolotowicz B, Ferreyra M, Milillo MA, Mascarau R, Moraña EJ, Palmero D, Matteo M, Fuentes F, López B, Barrionuevo P, Neyrolles O, Cougoule C, Lugo-Villarino G, Vérollet C, Sasiain MDC, Balboa L. Genoula M, et al. PLoS Pathog. 2020 Oct 1;16(10):e1008929. doi: 10.1371/journal.ppat.1008929. eCollection 2020 Oct. PLoS Pathog. 2020. PMID: 33002063 Free PMC article. - S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK. Nasser MW, et al. Cancer Res. 2012 Feb 1;72(3):604-15. doi: 10.1158/0008-5472.CAN-11-0669. Epub 2011 Dec 12. Cancer Res. 2012. PMID: 22158945 Free PMC article.
References
- Eur J Immunol. 1990 Nov;20(11):2375-81 - PubMed
- Cell. 1980 Jan;19(1):207-15 - PubMed
- Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1616-20 - PubMed
- Proc Natl Acad Sci U S A. 1988 Sep;85(17):6232-6 - PubMed
- J Immunol. 1987 Jul 1;139(1):135-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials